Clinical trials: Congenital Atransferrinemia

Congenital Atransferrinemia

Apotransferrin in Atransferrinemia

• Active, not recruiting
• Age: All ages
• Phase 2

Atransferrinemia is a very rare disorder, which is caused by a deficiency of the protein transferrin. No regular treatment is available for these patients.

Trial name

NCT01797055

Testing

Human apotransferrin

Where

3 sites in Germany, Italy and 1 more

Volunteers

5 people

Sponsor

Prothya Biosolutions